Telix Expands Prostate Cancer Activity with GenesisCare Collaboration

Go back to Telix Expands Prostate Cancer Activity with GenesisCare Collaboration
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 10.03 -0.07 (0.69%)
Previous Close $10.10    52 Week High $2.18 
Open $10.04    52 Week Low $0.30 
Day High $10.04    P/E N/A 
Day Low $9.94    EPS $-3.32 
Volume 54,718